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Abstract Previous studies of laboratory strains of budding yeast had shown that when gene
copy number is altered experimentally, RNA levels generally scale accordingly. This is true when
the copy number of individual genes or entire chromosomes is altered. In a recent study, Hose
et al. (2015) reported that this tight correlation between gene copy number and RNA levels is not
observed in recently isolated wild Saccharomyces cerevisiae variants. To understand the origins of
this proposed difference in gene expression regulation between natural variants and laboratory
strains of S. cerevisiae, we evaluated the karyotype and gene expression studies performed by
Hose et al. on wild S. cerevisiae strains. In contrast to the results of Hose et al., our reexamination
of their data revealed a tight correlation between gene copy number and gene expression. We
conclude that widespread dosage compensation occurs neither in laboratory strains nor in natural
variants of S. cerevisiae.
DOI: 10.7554/eLife.10996.001
Introduction
Losses or gains of whole chromosomes, a condition known as aneuploidy, have a profound impact
on cell physiology. Gene expression studies in budding yeast, fission yeast, mammalian cells, and
plants revealed that this is due to the fact that changes in gene copy number result in changes in
gene expression (Chikashige et al., 2007; Huettel et al., 2008; Pavelka et al., 2010;
Sheltzer et al., 2012; Stingele et al., 2012; Torres et al., 2010; 2007). For example, in haploid
budding yeast strains harboring single chromosome gains, RNA levels of more than 90% of genes
located on the extra chromosome reflect the increased gene copy number (Dephoure et al., 2014;
Torres et al., 2007). Only few genes, such as histone and some ribosomal genes defy this trend
(Dabeva and Warner, 1987; Gunjan and Verreault, 2003; Libuda and Winston, 2006;
Moran et al., 1990; Sutton et al., 2001; Vilardell and Warner, 1997). Given that aneuploidy has
such a profound impact on the cell’s transcriptome and proteome it is not surprising that aneuploidy
affects virtually all aspects of cell physiology, generally having a negative impact on fitness
(Hassold and Jacobs, 1984; Hodgkin, 2005; Huettel et al., 2008; Lindsley et al., 1972;
Niwa et al., 2006; Stingele et al., 2012; Torres et al., 2007; Williams et al., 2008).
Aneuploidy not only affects gene expression through changes in gene copy number, the condi-
tion also causes transcriptional responses. For example, when chromosome gains or losses lead to a
decrease in growth rate, a stereotypic slow-growth transcriptional response known as the environ-
mental stress response (ESR) ensues (Gasch et al., 2000). The ESR is characterized by the down-reg-
ulation of growth-promoting genes and the up-regulation of stress response genes and has been
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reported to occur in response to aneuploidy in many organisms including laboratory yeast strains
(Sheltzer et al., 2012).
Changes in gene copy number not only can lead to transcriptional responses but also can elicit
dosage compensation, a gene regulatory mechanism that specifically compensates for alterations in
gene copy number at the gene expression level. Dosage compensation is best understood in the
context of sex chromosome-encoded genes (reviewed in Straub and Becker, 2007). For example in
mammals, an RNA-mediated mechanism silences expression of one copy of the X chromosome in
females thereby equalizing X chromosome-encoded gene expression between males and females
(Lee and Bartolomei, 2013). In Caenorhabditis elegans, gene expression of the two X chromosomes
is reduced by half in the hermaphrodite to match the expression of the single X chromosome in
males (Meyer, 2010). Dosage compensation can also affect specific loci. The perhaps best known
example is the histone locus in budding yeast (Osley and Hereford, 1981). When an extra copy of
the HTA1 gene (histone H2A) is introduced into budding yeast, mRNA turnover increases resulting
in normal HTA1 transcript levels (Moran et al., 1990; Osley and Hereford, 1981). It is important to
note that dosage compensation and transcriptional responses to aneuploidy can have the same
effect on a gene. Both can cause the down-regulation of a gene, but the mechanisms are distinct.
Transcriptional responses to aneuploidy are elicited by an aneuploid genome affecting a biological
pathway and are not restricted to the aneuploid chromosomes but impact expression of genes
located throughout the genome. In contrast, dosage compensation specifically alters the expression
eLife digest DNA inside cells is packaged into structures called chromosomes. Different species
can have different numbers of chromosomes, but when any cell divides it must allocate the right
number of chromosomes to each new cell. If this process goes wrong, cells end up with too many or
too few chromosomes. The presence of extra copies of the genes on the additional chromosomes
can cause the levels of the proteins encoded by those genes to rise abnormally, which can in turn
lead to cell damage and disease.
Proteins are produced using the information in genes via a two-step process. First, the gene’s
DNA is copied to create molecules of RNA, and these molecules are then translated into proteins. In
many organisms, the presence of extra chromosomes in a cell is matched by a corresponding
increase in the RNA molecules encoded by the extra genes. Some organisms, however, counteract
this effect through a process called dosage compensation. This process inactivates single genes or
whole chromosomes by various means, and ensures that normal levels of RNA are produced, even in
the presence of extra genes.
In 2015, researchers from the University of Wisconsin-Madison reported that dosage
compensation occurs in wild strains of budding yeast and effectively protects the yeast cells against
the harmful effects of having extra chromosomes. However, these findings conflicted with earlier
studies of laboratory strains of this yeast, which had reported that RNA levels increased along with
gene number.
Torres, Springer and Amon have re-analysed the data published in 2015, and now challenge the
findings of the previous study involving the wild yeast strains. The new re-analysis instead showed
that, like in laboratory yeast strains, gene number still correlates closely with RNA levels in the wild
yeast. This led Torres, Springer and Amon to conclude that, in contrast with the previous report,
there is currently no evidence that dosage compensation occurs in wild strains of yeast.
So why do the results of these two studies disagree? Torres, Springer and Amon identified
several issues concerning the original analysis made by the researchers from the University of
Wisconsin-Madison. For example, some of the strains included in the 2015 study were unstable and
were naturally losing the additional chromosomes that they’d acquired. Also, the thresholds set in
the analysis to identify dosage compensated genes do not appear to have been stringent enough.
Together, the new findings indicate that dosage compensation is a rare event in both wild and
laboratory strains of yeast.
DOI: 10.7554/eLife.10996.002
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of a gene whose copy number has been varied and its effects are thus restricted to the aneuploid
chromosome.
Experimental evolution studies suggest that selective pressures cause changes in karyotype such
as chromosome gains or losses (Dunham et al., 2002; Gresham et al., 2008). However, such aneu-
ploidies are usually transient evolutionary intermediates that, given time, are replaced with more
optimal solutions (Yona et al., 2012). A key question that arises from these studies is how prevalent
whole chromosome gains and losses are in wild yeast strains and how aneuploidies affect cell physi-
ology. Hose et al. (2015) addressed these questions. They isolated 47 wild yeast strains to identify
12 (26%) that harbored whole chromosome gains and/or losses. The detailed analysis of six of these
strains led them to the conclusion that aneuploidies are prevalent, stable and well-tolerated in wild
yeast strains. Based on gene expression analyses, they further concluded that tolerance to aneu-
ploidy is caused by dosage compensation mechanisms that buffer gene amplifications thereby pro-
tecting cells against the adverse effects of aneuploidy. They reported that gene-dosage
compensation functions at >30% of amplified genes.
To understand why dosage compensation mechanisms are rare in laboratory strains of budding
yeast, but highly prevalent in wild isolates, we reevaluated the karyotype and gene expression stud-
ies performed by Hose et al. (2015). This reexamination revealed that gene copy number and
expression are tightly correlated in wild S. cerevisiae strains. We conclude that dosage compensa-
tion is a rare occurrence in both, laboratory and natural variants of S. cerevisiae.
Results
Many wild yeast strains have heterogeneous karyotypes
Hose et al. (2015) isolated 47 wild yeast variants and determined their karyotypes by inferring the
copy number from genome sequencing data using depth of coverage. This analysis showed that 12
of these 47 strains harbor whole chromosome aneuploidies. DNA and RNA sequencing data for 6 of
these 12 aneuploid strains were deposited in the NCBI Sequence Read Archive (SRA) under acces-
sion SRP047341 and NCBI Gene Omnibus under accession GSE61532 referenced in Hose et al.
(2015). Three of these strains harbored one or two single chromosome gains in a diploid back-
ground. Strain K9 is a diploid strain carrying an extra copy of chromosomes IX and X (Figure 1A,G),
YPS1009 is diploid with an extra copy of chromosome XII (Figure 1B,G), and diploid strain
NCYC110 carries two extra copies of chromosome VIII (Figure 1C,G). In addition, Hose et al. (2015)
analyzed three strains with high levels of aneuploidy. These strains were strains YJM428, Y2189 and
K1 (Figure 1D–G).
We examined the karyotypes and gene expression of these strains and found the aneuploid
strains K9, YPS1009 and NCYC110 with low levels of aneuploidy to harbor relatively stable karyo-
types (Figure 1A–C). As discussed in more detail below, RNA levels also generally correlated well
with DNA levels, with aneuploid chromosomes overall showing a corresponding increase in gene
expression (Figure 1A–C). It is, however, noteworthy that strain K9 which harbors extra copies of
chromosome IX and X in the Hose et al. (2015) study was previously reported to be trisomic for
chromosome IX only, indicating that this strain exhibits some karyotypic instability (Kvitek et al.,
2008).
In contrast to the relatively stable strains K9, YPS1009, and NCYC110, a different picture
emerged from our analysis of strains YJM428, Y2189, and K1 that harbor complex karyotypes. Based
on the presence of non-integer DNA copy number states, we conclude that the described aneuploi-
dies are only present in subpopulations of cells (Figure 1D–F). The comparison between RNA and
DNA levels further revealed significant inconsistencies between the two data sets indicating that
some strains had changed their karyotypes between the two analyses (e.g. DNA and RNA copy num-
bers are very different in strains Y2189 and K1; Figure 1E,F). This discrepancy is problematic as
Hose et al. (2015) used the standard deviations (SD) of the DNA measurements to establish cutoffs
in their RNA data set to identify dosage compensated genes (discussed in detail below).
We also analyzed the karyotypes of the other six aneuploid variants UC5, WE372, T73, Y3, Y6,
and CBS7960 that were not characterized in detail by Hose and coworkers (both Figure 1 and Sup-
plementary file 1 in Hose et al., 2015; log2 ratios of normalized DNA copy numbers were provided
by A. Gasch). We found that strains T73, which is tetrasomic for chromosome VIII (analyzed below;
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Figure 1. DNA and RNA copy number of six wild S. cerevisiae strains. (A) DNA and RNA copy number analysis of strain K9 compared to K10. Log2
ratios of aneuploid vs. euploid DNA in the order of the chromosomal location of their encoding genes are shown on the top. DNA copy number of
chromosomes IX and X are shown in red. The graph below shows the average DNA copy number per chromosome. The graph below shows RNA copy
number averaged per chromosome relative to K10 (n = 1). (B) DNA and RNA copy number analysis of strain YPS1009 compared to YPS163. Data are
represented as in (A). Error bars represent the SD of the chromosome means from three biological replicates. Medians are identical to the means. (C)
DNA and RNA copy number analysis of strain NCYC110 compared to NCYC3290. Data are represented as in (A). Error bars represent the SD of the
chromosome means from three biological replicates. Medians are identical to the means. (D) DNA and RNA copy number analysis of strain YJM428
compared to YJM308. Log2 ratios of aneuploid vs. euploid DNA in the order of the chromosomal location of their encoding genes are shown on the
top. DNA copy number of chromosomes XII and XVI are shown in red. Arrows indicate an amplification of part of chromosome III (red) and a loss of
part of chromosome XV (green). The graph below shows the average DNA copy number per chromosome relative to strain YJM308. The graph below
shows RNA copy number averaged per chromosome. Error bars represent the SD of the chromosome means from two biological replicates. Medians
are identical to the means. Asterisk indicate significant deviations from the expected value as determined by a one sample t-test (p < 0.01). (E) DNA
and RNA copy number analysis of strain Y2189 compared to Y2209. Data are represented as in (D). Error bars represent the SD of the chromosome
means from two biological replicates. Medians are identical to the means. Asterisk indicate significant deviations from the expected value as
Figure 1 continued on next page
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Figure 4A), and WE372, which is trisomic for chromosome I to harbor stable karyotypes (Figure 2A).
However, DNA copy numbers in strains UC5, Y3, Y6, and CBS7960 exhibited non-integer DNA copy
number states indicating that the strains are heterogeneous (Figure 2B–E).
Analysis of the karyotypes of the other 35 wild strains (both Figure 1 and Supplementary file 1 in
Hose et al. (2015)) revealed that more than half of the strains harbored karyotype profiles consistent
with heterogeneity. Importantly, strains K10, YJM308, and Y2209 utilized as the euploid reference in
the gene expression analysis of the aneuploid wild strains YJM428, Y2189, K1, and K9 (Figure 2 in
Hose et al., 2015) appeared to harbor heterogeneous karyotypes (Figure 2F–H). In particular, strain
YJM308 harbors an amplification of chromosome XV and has lost part of chromosome III
(Figure 2G). We conclude that only 10.6% (5 out of 47) of the strains analyzed by Hose et al. (2015)
harbor relatively stable aneuploidies that are confined to 1 – 2 chromosomes.
As all strains studied by Hose et al. (2015) were derived from single colonies, our finding of sig-
nificant karyotype heterogeneity indicates that a large fraction of wild yeast strains grown under
standard laboratory conditions are unstable. The observed instability and heterogeneity of many
wild S. cerevisiae strains makes it likely that the aneuploidies in these wild isolates are a consequence
of culturing the natural variants under laboratory conditions to which they may be ill-adapted to,
instead of these strains being naturally aneuploid. Caution is therefore warranted when analyzing
growth rates, gene expression patterns and phenotypes of such wild yeast strains under laboratory
growth conditions.
Figure 2. Karyotypes of aneuploid wild S. cerevisiae strains Y3, Y6 UC5, CBS7960, and WE372 and euploid control
strains. (A–E) Relative DNA copy of WE372 (A), Y3 (B), Y6 (C), UC5 (D), and CBS7960 (E) compared to S288C. Log2
(aneuploid vs. euploid DNA) per gene relative (top) are shown in the order of the chromosomal location of their
encoding genes. DNA copy numbers of amplified chromosomes are shown in red. Bar graphs (bottom) represent
the DNA copy numbers averaged per chromosome. Asterisks indicate significant deviations from expected
integral value using one sample t test (p < 0.01). (F–G) Relative DNA copy of K10 (F), YJM308 (G), and Y2189
(H) compared to S288C. Log2 ratio (aneuploid vs. euploid DNA) per gene are shown in the order of the
chromosomal location of their encoding genes.
DOI: 10.7554/eLife.10996.004
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Gene expression levels correlate with gene copy number in wild
aneuploid S. cerevisiae strains
In our previous studies, we found RNA and DNA levels to be well-correlated in haploid laboratory
W303 strains carrying additional chromosomes (Dephoure et al., 2014; Torres et al., 2007).
Hose et al. (2015) reported that this coordination between DNA and RNA levels was not evident in
wild budding yeast isolates. Their conclusion was based on three analyses. In the first analysis, they
characterized six wild aneuploid isolates; in the second, they studied three euploid-aneuploid strain
pairs; and in the third analysis, they investigated two sets of strains each comprised of a series of
strains with increasing aneuploidies of one particular chromosome. To begin to understand the
mechanisms that could have led to the loss of dosage compensation mechanisms in laboratory
strains, we reanalyzed the data generated by Hose et al. (2015) using the methods we previously
employed to examine the effects of aneuploidy on gene expression in laboratory strains.
Analysis of wild yeast strains YJM428, Y2189, YPS1009, NCYC110, K1,
and K9
Hose et al. (2015) compared mRNA levels with DNA copy number of amplified genes across six
aneuploid wild yeast strains called K9, YPS1009, NCYC110, YJM428, Y2189, and K1 and concluded
that 38% (838 of 2,204) of amplified genes showed lower expression than predicted by their gene
copy number (light blue points in Figure 4A in Hose et al., 2015). We reevaluated their findings.
Because of karyotype heterogeneity in strains YJM428, Y2189, and K1 (Figure 1D–F), we did not
reanalyze these strains except to determine the false discovery rate discussed in detail below.
Strains YPS1009 and K9 are trisomic for chromosomes XII and IX+X, respectively, while NCYC110
harbors a tetrasomy of chromosome VIII. Our analysis revealed that the expression of all genes on
the aneuploid chromosomes increased proportionally with gene copy number (Figure 1A–C, 3A,
B). As predicted by a null model with no compensation, we found that the log2 ratios of expression
values of genes encoded by the triplicated chromosomes of these strains to fit a normal distribution
with a mean value very close to the predicted log2 ratio of 0.58 (mean log2 ratio = 0.55, R
2 = 0.99,
Figure 3A, middle panel, Figure 3B) for the trisomic strains and a log2 ratio of 1 (mean log2 ratio =
0.95, R2 = 0.97, Figure 3A, right panel) for the tetrasomic chromosome. No skewness in the distribu-
tions - more compensating or exacerbating - was noted as would be expected if a large fraction of
the genes encoded on the aneuploid chromosome were dosage compensated (skewness = 0.02 (3n)
and 0.07 (4n); Figure 3A). The distribution of log2 ratios of expression values of genes encoded by
euploid chromosomes also fit a normal distribution with the predicted log2 ratio of 0 (mean log2
ratio = 0.00, R2 = 0.99, Figure 3A left panel). These data are very much in line with what is observed
in aneuploid laboratory strains. RNA quantification of two disomic W303 strains (disomes V and XVI)
showed that the log2 ratios of expression values of genes encoded by the duplicated chromosomes
fit a normal distribution with a mean value very close to the predicted log2 ratio of 1 (mean log2 ratio
= 1.03, R2 = 0.98, Figure 3C).
To determine how many genes were potentially subject to dosage compensation, we used 2 SD
from the means of the log2 ratios of each amplified chromosome and found that between 0% (0
gene in NCYC110) and 3% (19 genes in K9) of amplified genes showed values lower than expected
(Table 1). Importantly, a similar number of genes was found to exhibit higher than expected expres-
sion (between 1% in YPS1009 and 2% in NCYC110, Table 1). Using the same cutoff on the euploid
chromosomes, we found between 0.1% (7 genes in NCYC110) and 3% (153 genes in K1) genes with
values lower than expected. The nature of the distributions of gene expression patterns (normal dis-
tribution with expected means) and these analyses are inconsistent with high levels of dosage com-
pensation occurring in wild yeast strains. Instead, they indicate that gene expression proportionally
increases with copy number without signs of dosage compensation in wild yeast strains. The fact
that the euploid chromosomes encode the same proportion of up and downregulated genes as the
aneuploid chromosomes further indicates that any effects on gene expression seen in these strains
are likely to be the consequence of measurement noise or a transcriptional response elicited by the
aneuploid state rather than dosage compensation.
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Figure 3. RNA levels correlate with DNA copy number in wild and laboratory strains of S. cerevisiae. (A)
Histogram of the log2 ratios of the RNA copy number of genes located on euploid chromosomes (left panel,
strains YPS1009, NCYC110, and K9), genes present on trisomic chromosomes (3n, middle panel, YPS1009, and K9),
and genes present on tetrasomic chromosomes (right panel, NCYC110), relative to euploid controls are shown. Bin
size for all histograms is log2 ratio of 0.2, medians are identical to means. Fits to a normal distribution (black line),
means and goodness of fit (R2) and skewness are shown for each distribution. (B) The average log2 (aneuploid vs.
euploid RNA) of triplicated genes plotted against average log2 (aneuploid vs. euploid DNA) in strains YPS1009
and K9. Histogram of the log2 ratios of the DNA copy number is shown in red (mean log2 ratio = 0.57, SD = 0.14,
R2 = 1.0, skewness = 0.00). Histogram of the log2 ratios of the RNA copy number of is shown in blue (median =
mean = 0.55, skewness = 0.02). Fits to a normal distribution are shown (black line). Numbers of genes that show
RNA copy numbers lower or higher than 1 or 2 SD from the mean are shown (separated by dotted lines). (C)
Histogram of the log2 ratios of the RNA copy number of genes located on euploid chromosomes (left panel), and
Figure 3 continued on next page
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Analysis of the aneuploid strain pairs YPS163, T73, and YJM428
To further characterize dosage compensation in wild variants Hose et al. (2015) generated a panel
of isogenic euploid and aneuploid strain pairs. They isolated a disomic strain for chromosome VIII
(YPS163-chr VIII-2n) of the euploid strain YPS163, and euploid versions of strain T73, which is tetra-
somic for chromosome VIII (T73-chrVIII-4n) and of strain YJM428, which is tetrasomic for chromo-
some XVI (YJM428-chrXVI-4n). They then determined DNA copy number state and gene expression
levels in these strains and concluded that between 11 and 36% of genes were expressed at lower
than expected levels, that is, they were dosage compensated.
We compared the average chromosome copy number in the three aneuploid strains with the
average RNA copy number in these strains and found that RNA levels proportionally increased with
DNA copy number (Figure 4A,B). The aneuploidies in the three strains represent duplications. We
were, therefore, able to combine the duplicated values of the DNA and RNA copy of all the three
strains. The 941 duplicated genes showed a mean log2 ratio of 1.02 (SD = 0.29, R
2 = 0.99) for DNA
copy number and a nearly identical mean log2 ratio (mean = 0.97; SD = 0.36, R
2 = 0.99) for RNA
copy number (Figure 4C). Furthermore, the distribution of expression values fit a normal distribution
and was indistinguishable from the distribution of the gene expression values of genes encoded by
the euploid chromosomes. The standard deviations of the RNA distributions were similar for euploid
and aneuploid chromosomes (Figure 4C bottom graphs) and each distribution showed skewness of
0.01 and 0.02, respectively. These observations indicate that the variance of the euploid genes is the
same as that of the aneuploid genes. If dosage compensation were to occur, variance and skewness,
would be different between genes encoded by euploid and aneuploid chromosomes. Lastly, using 2
SD as cutoff to find potential dosage compensated genes, we identified a small number of outliers.
Importantly, the number of up and downregulated outliers was similar (Figure 5). We conclude that
RNA levels correlate well with DNA copy number in aneuploid strains YPS163, T73, and YJM428.
Analysis of the aneuploid strain series YPS1009 and NCYC110
The third set of strains that Hose et al. (2015) analyzed was comprised of two series of yeast strains
that carry increasing numbers of a specific chromosome. Starting with strain YPS1009, which carries
three copies of chromosome XII (YPS1090-chrXII-3n), Hose et al. (2015) derived a euploid strain
(YPS1009-chrXII-2n) and a strain that is tetrasomic for chromosome XII (YPS1009-chr XII-4n;
Figure 6A,B). Using strain NCYC110, which carries four copies of chromosome VIII (NCYC110-
chrVIII-4n), they isolated a strain trisomic for chromosome VIII (NCYC110-chrVIII-3n) and a diploid
strain (NCYC110-chrVIII-2n; Figure 6A,B). They then determined DNA copy number state and gene
expression levels in these strain series and concluded that 11% of genes encoded on chromosome
VIII and 29% of genes encoded on chromosome XII were dosage compensated.
We found the gene expression distribution of genes located on euploid and aneuploid chromo-
somes to fit normal distributions without any skewness (Figure 6C,D). The two trisomic strains
YPS1009-chrXII-3n and NCYC110-chrVIII-3n together harbored 776 triplicated genes. Their averaged
log2 ratio of DNA copy number was 0.57 (SD = 0.15, R
2 = 0.99) and 0.60 (SD = 0.53, R2 = 0.97) for
RNA copy number (Figure 6C). A similar coordination between DNA and RNA copy number was
observed in the tetrasomic strains. The mean log2 ratio of DNA copy number of genes located on
the tetrasomic chromosome was 0.99 (SD = 0.16, R2 = 0.99), the mean mRNA expression of genes
located on the tetrasomic chromosome was 0.99 (SD = 0.62, R2 = 0.96; Figure 6D). Importantly, the
distributions of DNA and mRNA copy number were similar for genes located on euploid, trisomic
and tetrasomic chromosomes, with similar SDs and no evidence of skewness (skewness varied
between 0.00 and 0.03).
In summary, we were not been able to detect dosage compensation in the strains described in
Hose et al. (2015). RNA levels of genes encoded by the aneuploid chromosomes are normally dis-
tributed with the expected or close to expected mean. No difference was observed between the
number of down-regulated genes located on aneuploid and euploid chromosomes. Furthermore, no
skewness was observed for any of the distributions. Figure 7 shows how distributions exhibit nega-
tive values of skewness when dosage compensation occurs. Importantly, in a previous study, we
were able to detect attenuation in the expression of certain genes in aneuploid yeast strains using
the method employed here. In Dephoure et al. (2014), we examined the proteomes of haploid
disomic laboratory yeast strains and found that production of ribosomal proteins encoded on
Torres et al. eLife 2016;5:e10996. DOI: 10.7554/eLife.10996 8 of 19
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Table 1. DNA and RNA copy number of six wild S. cerevisiae strains. The columns describe the following parameters: Column 1:
Strain name. Column 2: Identity of chromosomes amplified in each strain. Euploid represents the combined data of all euploid
chromosomes in a given strain. Column 3: Reported chromosome copy number. Column 4: Number of genes quantified by RNA-
seq. Column 5: Mean of the normalized log2 ratios (aneuploid vs. euploid RNA). Column 6: Standard deviation (SD) of the normalized
log2 ratios (aneuploid vs. euploid RNA). Column 7: Mean of the normalized log2 ratios (aneuploid vs. euploid DNA). Column 8:
Standard deviation (SD) of the normalized log2 ratios (aneuploid vs. euploid DNA). Column 9: Number of genes whose values are
below two SD from the mean. Column 10: Number of genes whose values are above two SD from the mean. Column 11: Cutoff used
by Hose et al. (2015) to identified genes that are dosage compensated.
1 2 3 4 5 6 7 8 9 10 11









YJM428 -1 XII 3 525 0.52 0.63 15
XVI 4 485 0.95 0.66 9 17
Euploid 2 5087  0.01 0.72 116 169
YJM428-2 XII 3 533 0.54 0.70 0.60 0.22 10 18 N/A
XVI 4 490 0.92 0.63 0.96 0.23 11 18 N/A
Euploid 2 5160  0.01 0.72 0.00 0.28 75 183
Aneuploid genes 9 (1%) 14 (1%)
Euploid genes 36 (1 %) 77 (1%)
Y2189-1 I 4 88 0.77 0.89 3 4
III 3 170 0.60 0.88 5 3
IX 3 216 0.42 0.91 5 9
XI 3 325 0.37 0.89 3 8
Euploid 5209 0.05 0.76 104 204
Y2189-2 I 4 89 0.63 1.01 1.05 1.04 4 3 0.21
III 3 167 0.53 0.90 0.53 0.55 5 6 0.24
IX 3 214 0.37 0.96 0.45 0.48 5 9 N/A
XI 3 324 0.46 0.65 0.47 0.25 3 10 0.13
Euploid 2 5231 0.06 0.77 0.00 0.43 142 165
Aneuploid genes 9 (1%) 15 (2%)
Euploid genes 50 (1%) 124 (2%)
YPS1009-1 XII 3 511 0.53 0.62 13 27
Euploid 2 5482 0.00 0.57 132 136
YPS1009-2 XII 3 520 0.49 0.73 16 20
Euploid 2 5531 0.00 0.60 145 119
YPS1009-3 XII 3 521 0.56 0.66 0.62 0.24 11 31 0.10
Euploid 2 5532 0.00 0.56 0.00 0.31 130 180
Aneuploid genes 5 (1%) 5 (1%)
Euploid genes 46 (1%) 27 (0%)
NCYC110-1 VIII 4 288 0.97 0.61 3 14
Euploid 2 5806 0.00 0.62 69 274
NCYC110-2 VIII 4 294 0.93 0.59 4 14
Euploid 2 5919 0.00 0.61 60 247
NCYC110-3 VIII 4 292 0.98 0.58 0.98 0.16 4 14 0.10
Euploid 2 5890 0.00 0.57 0.00 0.12 61 254
Aneuploid genes 0 (0%) 5 (2%)
Euploid genes 7 (0%) 102 (2%)
Table 1 continued on next page
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disomic chromosomes is significantly attenuated causing the distributions to exhibit negative skew-
ness (Dephoure et al., 2014).
Evaluation of the analysis methods employed by Hose et al. (2015)
Why did Hose et al. (2015) arrive at such different conclusions than we did? To address this ques-
tion, it is important to understand how Hose et al. (2015) analyzed and interpreted their data.
We identified two problems in their data analysis. The first regards data normalization. The ratios
are off by a factor of log2 = 0.1–0.2 (normalized data utilized in Hose et al. (2015) were kindly pro-
vided by A. Gasch). Most normalization protocols do not take into account that aneuploid strains
harbor a different number of gene copies compared to euploid strains. When this is not manually
corrected, data are shifted by a factor that depends on the degree of aneuploidy and results in
incorrect values as shown in Figure 8A. The degree by which the data used for analysis by
Hose et al. (2015) deviate from the correctly normalized expression values is of the same magnitude
as some of the cutoffs used to define dosage compensated genes (detailed next).
The second problem with the data analysis concerns cutoffs used to define dosage compensated
genes. To establish cutoffs for designating whether a gene is dosage compensated or not
Hose et al. (2015) used the SD of the DNA measurements, which ranged between 0.1 and 0.45
(Table 1 column 11, data kindly provided by A. Gasch) as cutoffs for the RNA measurements (Figure
4 in Hose et al., 2015). Genes whose expression deviated by the DNA SD value from the expected
RNA expression level were considered dosage compensated. This is not the correct cutoff tool
because the DNA copy number measurements are less variable than mRNA measurements. As seen
in Figure 8B, transcript levels can vary by several orders of magnitude depending on the expression
levels of a particular gene. Therefore, the distributions of relative RNA changes will show bigger SDs
than gene copy number distributions. Indeed, the RNA measurements conducted by Hose et al.
(2015) show SDs between 0.53 and 1.01 (Table 1, column 6). Employing the SD derived from the
DNA measurements, which are fairly lower (Table 1, column 8), will therefore not identify genes that
are dosage compensated in a statistically significant manner (see false discovery rate discussion
below). This is of particular importance as genes identified in Figure 4 of Hose et al. (2015) as dos-
age compensated were included in a group of 245 dosage compensated genes used to establish
GO term enrichments among dosage compensated genes.
To determine how Hose et al. (2015) identified 838 of 2204 genes as dosage compensated we
re-evaluated their analysis. Figure 4A in Hose et al. (2015) displays an unusual behavior. The null
model shown by the diagonal of equal RNA and DNA in this figure did not bisect the blue (compen-
sated) and magenta (exacerbated) points. Instead, the vast majority of points below this line were
considered compensated while the vast majority of points above this line were considered not exac-
erbated. This suggests that there could be a high number of false positives amongst the 838 genes
determined to be dosage compensated.
To address this possibility, we used two methods to determine the false discovery rate. First, we
scrambled the data by randomly permuting the RNA/DNA ratio between genes. We did this inde-
pendently for each replicate. This preserves the RNA/DNA ratios but unlinks the values from their
replicate measurements and genes. Then, we used the same effective significance cutoffs used by
Hose et al. (2015) to determine the number of dosage compensated genes (see
Materials and methods). As this is a randomized dataset, genes identified by this method are noise
and can be used to determine the number of genes the analysis method would find just by chance.
Based on 10,000 randomizations, we determined that on average, 779 genes would have passed the
threshold method used by Hose et al. (2015) by chance. This yields a false discovery rate (FDR) of
92.9%. This high false discovery rate was also seen at much lower cutoffs. The FDR was between 93
and 100% at cutoffs from 0.1 STD to 2 STDs.
Second, we calculated the average SD for each RNA sequencing measurement. As the DNA
measurements for each strain were not reported independently, we calculated the average chromo-
some-wide DNA error from all the sequencing data that were deposited and used the lowest of
these as an estimate for all analyses. We combined these errors together (square root of summed
squares of the two composite noises) to give a measurement noise distribution for the experiment.
We then randomly sampled from a normal distribution where the SD for this normal distribution was
randomly sampled from the measurement noise distribution. Using this method, we found that on
average, 754 genes would have passed the effective threshold used by Hose et al. (2015). This
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Figure 4. DNA and RNA copy number of euploid and aneuploid isogenic wild S. cerevisiae strains. (A) Plots for
strains YPS163-chrVIII-2n, T73-chrVIII-4n, and YJM428-chrXVI-4n, represent the log2 ratio of their relative DNA copy
number compared to their isogenic and euploid counterparts. DNA copy numbers are shown in the order of the
chromosomal location of their encoding genes (left). DNA copy numbers of amplified chromosomes are shown in
red. Bar graphs on the right represent the RNA copy numbers averaged per chromosome for aneuploid strains
relative to euploid reference strains. The average RNA copies of non-amplified chromosomes are shown in black.
Amplified chromosomes, as predicted by the karyotype, are shown in blue. (B) Gene expression of three
aneuploid strains ordered by chromosome position. Experiments (columns) of two biological replicates are shown.
(C) Histogram of the log2 ratios of the DNA (top) and RNA (bottom) copy number of genes located on euploid
chromosomes (left) and genes located on duplicated chromosomes (right) relative to euploid controls are shown.
Bin size for all histograms is log2 ratio of 0.2, medians are identical to means and all distributions show a skewness
of 0.01. Fits to a normal distribution are shown (black line) and so are means and goodness of fit (R2) for each
distribution.
DOI: 10.7554/eLife.10996.007
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corresponds to a false discovery rate of 89%; this value is likely a small underestimation of FDR given
our method for estimation of DNA error. We conclude that both methods that we applied to deter-
mine false discovery rate strongly suggest that only a handful, at most ~70 genes or <3%, are actu-
ally dosage compensated. These results are completely in line with previous findings from laboratory
strains (Springer et al., 2010; Dephoure et al., 2014; Torres et al., 2007).
In a second approach to identify dosage compensated genes, Hose et al. (2015) defined genes
to be dosage compensated when the RNA levels did not increase with DNA copy number in their
YPS1009 (2N, 2N+1 chromosome XII, 2N+2 chromosomes XII) and NCYC110 (2N, 2N+1 chromo-
some VIII, 2N+2 chromosomes VIII) ploidy series. For this, they developed a mixture of linear regres-
sion (MLR) model to classify genes based on the slope and intercept of the RNA-gene copy
relationships. When RNA levels did not increase proportionately as DNA copy increased as evi-
denced by slopes lower than 1 in the MLR model, a gene was classified as dosage compensated and
categorizes as Class 3a in Table 1 in Hose et al. (2015). Thirty genes on chromosome VIII and 142
genes on chromosome XII were identified as dosage compensated through this method. This
method of identifying dosage compensated genes is problematic in several ways. First, because
there are only three data points per analysis, a single deviating data point can have a significant
impact on the slope. For example, a gene with values of log2 ratio = 0.3, 0.6 and 0.8 representing,
two, three, and four copies, respectively, will perfectly fit a straight line with the slope of 0.5 and
hence would be classified as dosage compensated according to the criteria in Hose et al. (2015)
even though none of the three data points significantly deviates from the mean value given a SD of
0.3 or higher (Figure 8C, Table 2). In fact, the majority (103 of 172) of class 3a genes (Table 1 and
Supplemental File 3 in Hose et al. (2015)) fit the MLR model with slopes of 0.5 or higher indicating
that their gene expression increases with copy number.
Because of these considerations, we reanalyzed the dosage compensation in chromosomes VIII
and XII by two methods. In the first, we calculated the mean and standard deviations for each of the
Figure 5. Comparison of DNA and RNA copy number distributions of strains YPS163, T73, and YJM428. The
average log2 (aneuploid vs. euploid RNA) of 941 genes located on duplicated chromosomes plotted against the
average log2 (aneuploid vs. euploid DNA) in strains YPS163, T73, and YJM428. Histogram of the log2 ratios of the
DNA copy number is shown in red. Histogram of the log2 ratios of the RNA copy number is shown in blue. Fits to
a normal distribution are shown (black line). The number of genes that show RNA copy numbers lower or higher
than 2 SD from the mean are shown (separated by dotted lines).
DOI: 10.7554/eLife.10996.008
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Figure 6. RNA copy number proportionally increases with DNA copy number in aneuploid series of wild S. cerevisiae strains. (A) Plots for strain series
YPS1009-XII-2n, YPS1009-XII-3n, YPS1009-XII-4n and strain series NCYC110-chrVIII-2n, NCYC110-chrVIII-3n, NCYC110-chrVIII-4n represent the DNA copy
number compared to their euploid counterparts. DNA copy numbers are shown in the order of the chromosomal location of their encoding genes.
DNA copy numbers of amplified chromosomes are shown in red. Bar graphs below represent the RNA copy numbers averaged per chromosome for
aneuploid strains relative to euploid reference strains. The average RNA copies of non-amplified chromosomes are shown in black. Amplified
chromosomes, as predicted by the karyotype, are shown in blue. (B) Gene expression of strain series YPS1009-XII-2n, YPS1009-XII-3n, YPS1009-XII-4n,
and strain series NCYC110-chrVIII-2n, NCYC110-chrVIII-3n, NCYC110-chrVIII ordered by chromosome position. Experiments (columns) of three
biological replicates are shown. (C) Histogram of the log2 ratios of the DNA copy number of genes located on euploid chromosomes (top left) and
genes located on trisomic chromosomes (top right) in strains YPS1009-chrXII-3n and NCYC110-chrVIII-3n relative to euploid controls are shown. Fits to a
normal distribution are shown (black line). Histogram of the log2 ratios of the RNA copy number of genes located on euploid chromosomes (bottom
left) and genes present on trisomic chromosomes (bottom right) in strains YPS1009-chrXII-3n and NCYC110-chrVIII-3n relative to euploid controls are
shown. Fits to a normal distribution are shown (black line). (D) Histogram of the log2 ratios of the DNA copy number of genes located on euploid
chromosomes (top left) and genes located on tetrasomic chromosomes (top right) in strains YPS1009-chrXII-4n and NCYC110-chrVIII-4n relative to
euploid controls are shown. Fits to a normal distribution are shown (black line). Histogram of the log2 ratios of the RNA copy number of genes located
on euploid chromosomes (bottom left) and genes located on tetrasomic chromosomes (bottom right) in strains YPS1009-chrXII-4n and NCYC110-
chrVIII-4n relative to euploid controls are shown. Fits to a normal distribution are shown (black line).
DOI: 10.7554/eLife.10996.009
Torres et al. eLife 2016;5:e10996. DOI: 10.7554/eLife.10996 13 of 19
Research article Cell biology Genes and chromosomes
biological replicates in the NCYC110 and YPS1009 strain series and found that only two genes on
aneuploid chromosome VIII and seven genes on aneuploid chromosome XII show log2 ratios 1 SD
lower than the mean in three biological replicates and were reproducibly lower when present in 3 or
4 copies. Not a single gene passed the cutoff of 2 SD below the mean. We conclude that for the
majority of genes only one of the two data points supports the conclusion that a gene is expressed
at lower than the expected value, calling into question that the genes identified by this approach are
indeed dosage compensated.
In a second approach, we defined the false discovery rate (not determined by Hose et al., 2015)
to determine whether the genes identified as dosage compensated were statistically distinguishable
from noise. Using the same subset of genes that Hose et al. (2015) examined, we calculated a slope
based on the nine RNA measurements and matching DNA measurements (three replicates of three
strains) for both YPS1009 and NCYC110. Using the genes identified as dosage compensated by
Hose et al. (2015), we determined the effective cutoff of their MLR method (see
Materials and methods). We then randomly permuted the positions of the RNA and DNA data and
recalculated the slopes for each gene. From this analysis we determined the false discovery rate was
within error of 100%. We conclude that there is no significant dosage compensation in these aneu-
ploid series.
Discussion
Our analyses indicate that a large fraction of wild S. cerevisiae strains are unstable and heteroge-
neous when grown under laboratory conditions. This result suggests that at least some wild S. cere-
visiae strains may not be naturally aneuploid but could become aneuploid due to an adaptive
response to laboratory growth conditions. Reevaluation of the DNA and RNA copy number data
generated by Hose et al. (2015) further indicates that dosage compensation is rare in both wild and
laboratory strain of S. cerevisiae. Both types of strains lack mechanisms that allow them to attenuate
gene expression in response to gene copy number alterations. We conclude that wild variants of S.
cerevisiae do not have mechanisms in place that protect them from changes in gene copy number.
Their regulation of gene expression is thus the same as that of laboratory strains of budding yeast.
Figure 7. Theoretical distribution of RNA copy number of dosage compensated duplicated genes. The theoretical
distribution of RNA copy number of duplicated genes when no dosage compensation takes place is shown in
blue. The theoretical distribution of RNA copy number of duplicated genes when 30% of the genes are dosage
compensated is shown in red. The fit to a normal distribution shows negative skewness values (red).
DOI: 10.7554/eLife.10996.010
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Figure 8. Evaluation of the analysis tools employed by Hose et al. (2015). (A) RNA copy numbers averaged per
chromosome of normalized RNA-seq data obtained by Hose et al. (2015). Data provided by Hose et al. (2015).
(B) Standard deviations of RNA-seq data are greater than those of DNA-seq data. Histograms of DNA-seq RPKM
and RNA-seq RPKM for strain K10 are shown. (C) Linear regression fits of RNA versus DNA copy number are
shown for several genes identified as class 3a dosage compensated genes by Hose et al. (2015). Eight genes
from chromosome XII and two genes from chromosome VIII are shown. Average log2 ratio of aneuploid vs.
euploid RNA is shown. Error bars represent SD from three biological replicates.
DOI: 10.7554/eLife.10996.011
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Materials and methods
Karyotype heterogeneity analysis
We consider any chromosome whose copy number was significantly different from an integral value
to be heterogeneous. To determine which chromosomes were significantly different than the nearest
integer value, we used a one sample t test using the copy number of each gene on the chromosome
as the input which compares a distribution of values to an expected value and then corrected for
multiple hypothesis testing. In strain YJM428, the expected value for chromosome III is 2 and the
expected value for chromosome XV is 2. In strain Y2189, the expected value for chromosome I is 4,
and for chromosomes IX and X is 3. In strain K1, the expected value for chromosomes I and VI is 2.
In strains Y3 and Y6, the expected value for chromosome VIII is 3. In strain UC5, the expected value
for chromosome I is 2. In strain CBS7960, the expected value for chromosomes I and III is 1. In strain
WE372, the expected value for chromosome I is 3.
Data processing
To avoid any discrepancies in data processing, Hose and coworkers kindly provided all the relative
log2 ratios of the relative DNA copy number for all 47 wild strains and for the different panel of iso-
genic strains. In addition, Hose and coworkers kindly provided all gene expression data utilized in
their manuscript. In addition, genome sequences for 16 distinct karyotypes (eight aneuploid and
eight euploids) could be obtained from the NIH Sequence Read Archive (SRA) under accession
SRP047341. Gene expression data could also be obtained from NIH GEO under accession
GSE61532.
Data normalization
Log2 ratios provided by Hose et al. (2015) were normalized by centering the euploid chromosome
ratios to 0. This was accomplished by calculating the mean of the log2 ratios of non-duplicated
Table 2. RNA copy number of aneuploid chromosomes in strain series NCYC110 and YPS1009. Analysis of genes encoded by
chromosome VIII in strains NCYC110-2n, NCYC110-3n, NCYC110-4n (top) and encoded by chromosome XII in strains YPS1009-2n,
YPS1009-3n, YPS1009-4n. One SD was used as a cutoff to identified genes with lower than expected RNA levels in each biological
replicate. The “All 3 replicates” line represents genes whose RNA levels are reproducibly lower than expected in 3 RNA-seq
experiments. Line “Both 3n and 4n” represent the number of genes whose RNA levels are lower than expected in trisomic and
tetrasomic strains.
NCYC110
ChrVIII.2n-1 ChrVIII.2n-2 ChrVIII.2n-3 ChrVIII.3n-1 ChrVIII.3n-2 ChrVIII.3n-3 ChrVIII.4n-1 ChrVIII.4n-2 ChrVIII.4n-3
Mean 0.04 -0.02 0.02 0.54 0.51 0.61 0.97 0.91 0.99
Number of genes 282 285 283 284 286 282 285 286 284
SD 0.53 0.56 0.54 0.51 0.50 0.54 0.57 0.55 0.56
Mean - 1*SD 23 18 20 29 25 22 24 33 29
All 3 replicates 3 12
Both 3n and 4n 1 2
YPS1009
Chr XII-2n-1 Chr XII-2n-2 Chr XII-2n-3 Chr XII-3n-1 Chr XII-3n-2 Chr XII-3n-3 Chr XII-4n-1 Chr XII-4n-2 Chr XII-4n-3
Mean 0.01 0.04 0.06 0.57 0.57 0.60 0.93 0.96 1.00
Number of genes 495 500 496 498 499 499 499 499 500
SD 0.41 0.52 0.46 0.46 0.47 0.51 0.65 0.66 0.66
Mean - 1*SD 42 56 36 47 50 46 46 52 45
All 3 replicates 8 15 17
Both 3n and 4n 3 7
DOI: 10.7554/eLife.10996.012
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genes and subtracting this factor from all data points. Chromosome copy numbers were calculated
by taking the average copy number of all genes within each chromosome. For diploids copy number
equals 2*2^(log2 ratio euploid vs. aneuploid), for haploids copy number equals 1*2^(log2 ratio euploid
vs. aneuploid).
Gene expression data of each aneuploid strain were compared to their reference genome as
described in Hose et al. (2015). Log2 ratios of aneuploid/euploid genes were normalized to the
euploid chromosomes as described above for DNA. RNA copy numbers per chromosome were cal-
culated by averaging gene copy number of the genes within each chromosome.
RNA and DNA distribution analysis of euploid and amplified genes
To analyze the distributions of euploid or amplified genes, DNA and RNA log2 ratios of aneuploid/
euploid we first calculated the distribution of the log2 ratios binned by a value of 0.2. The frequency
distributions were plotted and the data were fit to normal distribution utilizing PRISM software.
Means, medians, SD, skewness and R2 of the fits are reported in each figure. Gene expression data
for disomes V and XVI (Figure 3C) were previously published in Dephoure et al. (2014). Gene
expression profiles were visualized with Treeview.
Determination of false discovery rate
Permutation
First, we needed to determine an effective cutoff to classify a gene as dosage compensated. We cal-
culated the RNA/DNA ratio or slope of RNA versus DNA for all genes and binned the data (0.1
width bins in log space). For each bin, we then determined the percent of genes in that bin that
were classified as dosage compensated by Hose et al. (2015). Second, we randomized the data.
We took the processed data (RNA/DNA) or raw data (RNA and DNA measurements, for slope analy-
sis) and randomized the position of this information in the dataset. This decouples all the replicate
measurements. Hose et al. (2015) supplied us with the RNA and DNA values for each gene and for
each strain that they used to assess dosage compensation. Starting with this table as our input for
randomization, we then calculated the RNA/DNA ratio for every replicate of every gene. We then
permuted each column of the table (the replicates) independently and then calculated the average
dosage compensation per ’gene’ by averaging across the replicates; this is identical to how
Hose et al. (2015) calculated dosage compensation from the unpermuted table.
If a subset of genes on a chromosome are compensated, as reported by Hose et al. (2015), their
average RNA/DNA ratios should appear as outliers on a distribution of RNA/DNA for a whole chro-
mosome. Randomization of the RNA/DNA values before averaging will eliminate most of these out-
liers, as the outlying values will be most often average with non-outlying values; hence one should
observe fewer genes that have large deviations from the mean. To assess this, we took all genes
that Hose et al. (2015) had reported as dosage compensated. We took the distribution of RNA/
DNA for these compensated genes and called this the observed or reported compensated distribu-
tion. The existence of true compensators would lead to significantly more genes in the compensated
distribution than in the randomized distribution for a given dosage compensation range. This was
not the case. Instead, the distributions were indistinguishable suggesting that the vast majority of
genes reported as dosage compensated by Hose et al. (2015) is noise.
Random sampling based on noise
Before calculating the false positive rate, one minor correction was needed. As the cutoff for calling
a gene dosage compensated in Hose et al. (2015) did not take into account all the measurement
noise we had to determine the effective cutoff used by Hose et al. (2015).
While the RNA values were reported for each of the replicates, the DNA value was only reported
as the mean of all measurements. This meant that calculating a SD based on the RNA/DNA ratios
reported by Hose et al. (2015) would underestimate the true error of the measurement of dosage
compensation and hence would give an artificially low false discovery rate. We turned to the
sequencing data deposited with the paper, but the DNA data was only deposited for a subset of the
strains. We therefore calculated the per gene DNA copy number error from the strains from which
the replicates were deposited. From this, we found that the average standard deviation in DNA
copy number was approximately 10%. For each dosage compensation value, we therefore randomly
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sampled from a normal distribution with a SD of 10% and modified the dosage compensation value
by this percentage (square root of squared sum of errors).
To determine the false discovery rate of this compensated distribution we compared the distribu-
tion of dosage compensated genes to the distribution of dosage compensation data from a distribu-
tion obtained by randomly sampling from a normal distribution with errors that came from a table of
measurement errors. If we did not include the DNA error in this table of measurement estimates, the
FDR rates dropped by about 10%. Thus, the vast majority of dosage compensated genes are most
likely false positives irrespective of whether a correction was included or not.
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